ETF Managers Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $3.08M | Buy |
+51,133
| New | +$3.08M | 0.1% | 132 |
|
|
2022
Q4 | – | Sell |
-49,367
| Closed | -$3.75M | – | 642 |
|
|
2022
Q3 | $3.75M | Buy |
49,367
+3,724
| +8% | +$283K | 0.12% | 125 |
|
|
2022
Q2 | $3.31M | Sell |
45,643
-15,052
| -25% | -$1.09M | 0.1% | 137 |
|
|
2022
Q1 | $5.1M | Sell |
60,695
-4,760
| -7% | -$400K | 0.1% | 134 |
|
|
2021
Q4 | $5.23M | Sell |
65,455
-3,443
| -5% | -$275K | 0.1% | 158 |
|
|
2021
Q3 | $8M | Sell |
68,898
-4,748
| -6% | -$552K | 0.15% | 134 |
|
|
2021
Q2 | $16.5M | Sell |
73,646
-9,646
| -12% | -$2.16M | 0.27% | 114 |
|
|
2021
Q1 | $10.4M | Buy |
83,292
+14,875
| +22% | +$1.86M | 0.19% | 123 |
|
|
2020
Q4 | $11.9M | Sell |
68,417
-30,172
| -31% | -$5.25M | 0.26% | 105 |
|
|
2020
Q3 | $10.7M | Buy |
98,589
+7,668
| +8% | +$836K | 0.34% | 94 |
|
|
2020
Q2 | $5.25M | Buy |
90,921
+7,118
| +8% | +$411K | 0.19% | 104 |
|
|
2020
Q1 | $5.87M | Buy |
83,803
+7,448
| +10% | +$522K | 0.27% | 89 |
|
|
2019
Q4 | $6.51M | Buy |
76,355
+8,005
| +12% | +$683K | 0.23% | 94 |
|
|
2019
Q3 | $5.02M | Buy |
68,350
+7,200
| +12% | +$529K | 0.18% | 91 |
|
|
2019
Q2 | $3.72M | Buy |
61,150
+10,238
| +20% | +$623K | 0.12% | 97 |
|
|
2019
Q1 | $2.45M | Sell |
50,912
-4,875
| -9% | -$235K | 0.12% | 89 |
|
|
2018
Q4 | $1.87M | Buy |
55,787
+3,420
| +7% | +$115K | 0.09% | 127 |
|
|
2018
Q3 | $2.74M | Buy |
+52,367
| New | +$2.74M | 0.1% | 106 |
|
|
2018
Q2 | – | Sell |
-41,049
| Closed | -$835K | – | 565 |
|
|
2018
Q1 | $835K | Buy |
41,049
+6,760
| +20% | +$138K | 0.05% | 179 |
|
|
2017
Q4 | $696K | Buy |
34,289
+8,929
| +35% | +$181K | 0.05% | 169 |
|
|
2017
Q3 | $503K | Buy |
25,360
+1,755
| +7% | +$34.8K | 0.04% | 98 |
|
|
2017
Q2 | $408K | Buy |
+23,605
| New | +$408K | 0.03% | 89 |
|